Does Dr. MANIKUMAR BHEEMARASETTI have financial conflicts of interest?

Dr. MANIKUMAR BHEEMARASETTI (MD) has received a total of $4,402 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $4,402 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MANIKUMAR BHEEMARASETTI?

According to CMS Open Payments data, Dr. MANIKUMAR BHEEMARASETTI received funding from ABIOMED ($777), ABBOTT LABORATORIES ($518), and JANSSEN PHARMACEUTICALS ($371).

Does Dr. MANIKUMAR BHEEMARASETTI receive research grants or speaking fees?

Dr. MANIKUMAR BHEEMARASETTI has received $4,402 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MANIKUMAR BHEEMARASETTI

MDReal-Time Hydrated

Specialty: Internal Medicine, Interventional Cardiology

Practice Location: ARLINGTON, TX 76012

NPI Number: 1497986533

LIFETIME INDUSTRY VALUE

$4,402

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BHEEMARASETTI is a verified Internal Medicine, Interventional Cardiology practitioner based in ARLINGTON, TX.

Between 2021 and 2025, Dr. BHEEMARASETTI had an overall industry promotional and research financial footprint of $4,402 as recorded in the federal CMS Open Payments database.

$4,402 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BHEEMARASETTI's primary funding source is ABIOMED, which accounts for $777 (representing 17.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABIOMED

Rank 1

$777

17.6%

ABBOTT LABORATORIES

Rank 2

$518

11.8%

JANSSEN PHARMACEUTICALS

Rank 3

$371

8.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.